LISATA THERAPEUTICS, INC. Income (Loss) from Equity Method Investments
LISATA THERAPEUTICS, INC. (LSTA) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-03-12
- LISATA THERAPEUTICS, INC. income (loss) from equity method investments for the quarter ending 2025-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from equity method investments for the quarter ending 2025-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from equity method investments for the quarter ending 2025-06-30 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from equity method investments for the quarter ending 2025-03-31 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from equity method investments for fiscal 2025 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from equity method investments for fiscal 2024 was -$130.00K.
- LISATA THERAPEUTICS, INC. income (loss) from equity method investments for fiscal 2023 was $0.00.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | -$30.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | -$30.00K derived: sum of 3 quarters · filed 2026-03-12 | -$30.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$30.00K derived: sum of 2 quarters · filed 2026-03-12 | -$30.00K derived: sum of 3 quarters · filed 2026-03-12 | -$130.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$30.00K 10-Q · filed 2025-11-06 | -$30.00K derived: sum of 2 quarters · filed 2025-11-06 | -$130.00K 10-Q · filed 2025-11-06 | -$130.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | -$100.00K 10-Q · filed 2025-08-07 | -$100.00K derived: sum of 3 quarters · filed 2025-08-07 | -$100.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$100.00K 10-Q · filed 2025-05-08 | -$100.00K derived: sum of 2 quarters · filed 2025-05-08 | -$100.00K derived: sum of 3 quarters · filed 2025-05-08 | -$100.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |